AU2002210683A1 - Identification of hla-dr restricted hcv epitopes - Google Patents

Identification of hla-dr restricted hcv epitopes

Info

Publication number
AU2002210683A1
AU2002210683A1 AU2002210683A AU1068302A AU2002210683A1 AU 2002210683 A1 AU2002210683 A1 AU 2002210683A1 AU 2002210683 A AU2002210683 A AU 2002210683A AU 1068302 A AU1068302 A AU 1068302A AU 2002210683 A1 AU2002210683 A1 AU 2002210683A1
Authority
AU
Australia
Prior art keywords
hla
identification
hcv epitopes
restricted
restricted hcv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002210683A
Inventor
Andrew James Godkin
Howard Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Publication of AU2002210683A1 publication Critical patent/AU2002210683A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002210683A 2000-10-25 2001-10-18 Identification of hla-dr restricted hcv epitopes Abandoned AU2002210683A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0026094.3A GB0026094D0 (en) 2000-10-25 2000-10-25 Methods
GB0026094 2000-10-25
PCT/GB2001/004636 WO2002034770A1 (en) 2000-10-25 2001-10-18 Identification of hla-dr restricted hcv epitopes

Publications (1)

Publication Number Publication Date
AU2002210683A1 true AU2002210683A1 (en) 2002-05-06

Family

ID=9901934

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002210683A Abandoned AU2002210683A1 (en) 2000-10-25 2001-10-18 Identification of hla-dr restricted hcv epitopes

Country Status (3)

Country Link
AU (1) AU2002210683A1 (en)
GB (1) GB0026094D0 (en)
WO (1) WO2002034770A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2843115B1 (en) * 2002-08-02 2007-11-09 Commissariat Energie Atomique MIXTURE OF PEPTIDES FROM PROTEINS C AND NS3 OF HEPATITIS C VIRUS AND THEIR APPLICATIONS
AU2003303889A1 (en) * 2003-01-07 2004-08-30 Biomerieux Polypeptides f' of the hepatitis c virus, epitopes, and the diagnostic and therapeutic applications thereof
CN103282375B (en) 2010-12-02 2017-01-11 比奥诺尔免疫有限公司 peptide scaffold design
CA2821995C (en) 2011-01-06 2019-02-12 Bionor Immuno As Monomeric and multimeric peptides immunogenic against hiv
JP6310909B2 (en) 2012-06-06 2018-04-11 ビオノール イミュノ エーエスＢｉｏｎｏｒ Ｉｍｍｕｎｏ Ａｓ Peptides derived from viral proteins for use as immunogens and dosing reactants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69434295T2 (en) * 1993-11-04 2006-02-16 Innogenetics N.V. Of human T-cells immunodominant epitopes of the virus of C-hepatitis
AU697171B2 (en) * 1994-04-08 1998-10-01 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Hepatitis C virus core peptide for stimulation of cytotoxic T lymphocytes and diagnosis of HCV exposure
AU6226100A (en) * 1999-07-19 2001-04-24 Epimmune, Inc. Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions

Also Published As

Publication number Publication date
GB0026094D0 (en) 2000-12-13
WO2002034770A1 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
AUPR464601A0 (en) Shapes vector
PL366621A1 (en) Core-glycosylated hcv envelope proteins
AU2001232054A1 (en) Vector
AU2002219900A1 (en) Minimal identification of features
AU2002210683A1 (en) Identification of hla-dr restricted hcv epitopes
AU2001282644A1 (en) Case
AU2002365927A1 (en) Vesicle-associated proteins
AU2001256161A1 (en) Nail
AU2002222139A1 (en) Hcv vaccines
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU4672401A (en) Vectors
AU2001244863A1 (en) Apoptin-associating protein
AU2002356682A1 (en) Switch lock
AU2001278975A1 (en) Alpha-conotoxin peptides
AU2001241044A1 (en) Mitf-associated proteins
AU2001278777A1 (en) Irap-binding protein
AU2002357850A1 (en) Neurotransmission-associated proteins
AU2001277614A1 (en) Novel proteins
AU2001294911A1 (en) Carbohydrate-associated proteins
AU2001290317A1 (en) Novel peptides
AU2002326909A1 (en) Neurotransmission-associated proteins
AU2002328853A1 (en) Carcinoma-related peptides
IL158422A0 (en) Core-glycosylated hcv envelope proteins
AU2001253019A1 (en) Novel proteins
AU2002230950A1 (en) Seleno-cysteine containing protein zsel1